Financial statements Syntalpharma

Balance sheet of Syntalpharma

Company age:
Age:
10 y. 6 m. 8 d.
Share capital:
Share capital:
300 000 PLN

Balance sheet data of SYNTALPHARMA

Year
2021
2022
2023
Total assets 1 618 549,92 2 150 351,70 2 577 340,97
A. Fixed assets 732 292,10 672 966,50 943 553,01
B. Current assets 886 257,82 1 477 385,20 1 633 787,96
C. Share capital contributions (basic funds) 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00
Total liabilities 1 618 549,92 2 150 351,70 2 577 340,97
A. Equity 72 571,98 630 736,19 1 112 047,09
B. Liabilities and provisions for liabilities 1 545 977,94 1 519 615,51 1 465 293,88
I. Long-term liabilities 1 341 189,82 1 436 410,42 1 458 325,86
II. Short-term liabilities 204 788,12 83 205,09 6 968,02
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.